$599
Esperion and Skye Bioscience Q2 ’24 Earnings; Sernova Appoints New CEO
Three cardiometabolic-related news items have been observed: Esperion (press release; slides) and Skye Bioscience (view press release) reported their respective Q2 ’24 earnings; and Sernova announced the appointment of a new CEO (view press release). Below, FENIX provides highlights and insights for the respective news items.